No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Global Ophthalmoscopes Market Report to 2030: Rising Incidence of Eye Diseases Drives Growth

Editor: What To Know

  • The increasing technological advancements in ophthalmic devices, the growing prevalence of eye disorders, and increasing healthcare expenditure, particularly in emerging economies, are the key factors driving the growth of the ophthalmoscopes market.
  • Direct ophthalmoscopes accounted for the largest market share in 2022 owing to rising usage for examining the optic disc, retina, and other structures at the back of the eye.
  • Such a rise in the incidence of eye disorders across the globe is anticipated to propel market growth.

The “Ophthalmoscopes Market Size, Share & Trends Analysis Report By Type (Direct, Indirect), By Application (Diabetic Retinopathy, Macular Degeneration, Retinal Repair, Glaucoma), By End-use (Hospitals), By Region, And Segment Forecasts, 2023 – 2030″ report has been added to ResearchAndMarkets.com’s offering.

The global ophthalmoscopes market size is expected to reach USD 408.7 million by 2030 to expand at a CAGR of 6.6% from 2023 to 2030.

Companies Mentioned

  • Welch Allyn
  • Keeler Ltd.co
  • Zumax medical co. ltd
  • Albert Waeschle
  • Neitz Instruments Co., Ltd.
  • US Ophthalmic
  • Heine USA Ltd
  • HONSUN Group
  • Rudolf Riester GmbH
  • Dino-Lite Europe

The increasing technological advancements in ophthalmic devices, the growing prevalence of eye disorders, and increasing healthcare expenditure, particularly in emerging economies, are the key factors driving the growth of the ophthalmoscopes market.

Portable ophthalmoscopes are handheld devices used to examine the eye’s interior including the retina, optic disc, and blood vessels. The growing demand for portable ophthalmoscopes is increasing due to their ease of use and convenience. They are typically used by optometrists, eye doctors, and other medical professionals.

Additionally, advancement in technology is also a primary factor contributing to the demand for ophthalmoscopes. Advancements in artificial intelligence (AI) and machine learning are being incorporated into ophthalmoscopes, allowing for the automatic detection and diagnosis of eye diseases. AI-powered ophthalmoscopes can analyze images of the retina and optic nerve, identifying patterns and anomalies that may be indicative of eye diseases.

More than 2.9 million Americans aged 40 and older have low vision. Nearly 4.2 million Americans aged 40 and older are visually impaired. Approximately 8% of men and 0.5% of women with Northern European ancestry have the most common form of color blindness that makes it hard to see red or green. Such a rise in the incidence of eye disorders across the globe is anticipated to propel market growth.

The key players are involved in strategies, such as entering into product launches, collaborations & agreements, and mergers & acquisitions, to expand its geographical presence.

For instance, in August 2022, Swaraashi Netralya announced the launch ophthalmic devices including ophthalmoscope to identify eye concerns among adults as well as children’s. The Mirante SLO/OCT, a scanning laser ophthalmoscope used to capture high-quality color images was launched in India.

Ophthalmoscopes Market Report Highlights

  • Direct ophthalmoscopes accounted for the largest market share in 2022 owing to rising usage for examining the optic disc, retina, and other structures at the back of the eye
  • Based on application, glaucoma accounted for the largest market share of 31.8% in 2022 and is the leading cause of blindness in the U.S. and across the globe
  • Ophthalmic clinics are anticipated to register the fastest CAGR growth during the forecast period
  • North America accounted for the largest share of 32.3% in 2022 owing to the growing prevalence of eye diseases & disorders and rising advancement

Key Attributes:

Report Attribute Details
No. of Pages 100
Forecast Period 2022 – 2030
Estimated Market Value (USD) in 2022 $245.2 Million
Forecasted Market Value (USD) by 2030 $408.7 Million
Compound Annual Growth Rate 6.6%
Regions Covered Global

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Ophthalmoscopes Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent market outlook

3.1.2. Related/ancillary market outlook

3.2. Market Dynamics

3.2.1. Market driver analysis

3.2.1.1. Growing incidence of eye diseases

3.2.1.2. Increasing technological advancements & government initiatives

3.2.1.3. Increasing awareness about eye health

3.2.1.4. Growing geriatric population

3.2.2. Market restraint analysis

3.2.2.1. Limited availability & technological limitations

3.2.2.2. High cost of ophthalmoscopes

3.3. Dental Regeneration: Market Analysis Tools

Chapter 4. Ophthalmoscopes Market: Type Estimates & Trend Analysis

Chapter 5. Ophthalmoscopes Market: Application Estimates & Trend Analysis

Chapter 6. Ophthalmoscopes Market: End-use Estimates & Trend Analysis

Chapter 7. Ophthalmoscopes Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

8.1. Company Profiles

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy